Sonic Healthcare Gets New Bear on Medicare Data Worries -- Market Talk

Dow Jones

Jan 27

0031 GMT - Sonic Healthcare gets a sell call from Citi, which says Australian Medicare data for pathology looks worse than it expected. "Sonic's results are not perfectly correlated but we have halved our near-term growth forecasts for Australia revenue [circa 20% of the top line] to 2.5%," says analyst Laura Sutcliffe. Citi also thinks Sonic's U.S. business could continue to underperform. It points to mid-single digit growth estimates from larger competitors which have recently outperformed Sonic. "Our 1H revenue estimates are near consensus, but we are 5% below for net profit," Citi says. "We put in place a negative 30-day catalyst watch." It downgrades Sonic to sell, from neutral, and lowers its price target by 11% to A$21.00. Sonic is down 2.9% at A$22.66. (david.winning@wsj.com; @dwinningWSJ)

(END) Dow Jones Newswires

January 26, 2026 19:31 ET (00:31 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2606220817"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2606220817\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2606220817?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-27 08:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2606220817","market":"hk","top_or_hot":-1,"title":"Sonic Healthcare Gets New Bear on Medicare Data Worries -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0031 GMT - <a href=\"https://laohu8.com/S/SKHCF\">Sonic Healthcare</a> gets a sell call from Citi, which says Australian Medicare data for pathology looks worse than it expected. \"Sonic's results are not perfectly correlated but we have halved our near-term growth forecasts for Australia revenue [circa 20% of the top line] to 2.5%,\" says analyst Laura Sutcliffe. Citi also thinks Sonic's U.S. business could continue to underperform. It points to mid-single digit growth estimates from larger competitors which have recently outperformed Sonic. \"Our 1H revenue estimates are near consensus, but we are 5% below for net profit,\" Citi says. \"We put in place a negative 30-day catalyst watch.\" It downgrades Sonic to sell, from neutral, and lowers its price target by 11% to A$21.00. Sonic is down 2.9% at A$22.66. (david.winning@wsj.com; @dwinningWSJ) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 26, 2026 19:31 ET (00:31 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sonic Healthcare Gets New Bear on Medicare Data Worries -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSonic Healthcare Gets New Bear on Medicare Data Worries -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-01-27 08:31</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0031 GMT - <a href=\"https://laohu8.com/S/SKHCF\">Sonic Healthcare</a> gets a sell call from Citi, which says Australian Medicare data for pathology looks worse than it expected. \"Sonic's results are not perfectly correlated but we have halved our near-term growth forecasts for Australia revenue [circa 20% of the top line] to 2.5%,\" says analyst Laura Sutcliffe. Citi also thinks Sonic's U.S. business could continue to underperform. It points to mid-single digit growth estimates from larger competitors which have recently outperformed Sonic. \"Our 1H revenue estimates are near consensus, but we are 5% below for net profit,\" Citi says. \"We put in place a negative 30-day catalyst watch.\" It downgrades Sonic to sell, from neutral, and lowers its price target by 11% to A$21.00. Sonic is down 2.9% at A$22.66. (david.winning@wsj.com; @dwinningWSJ) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 26, 2026 19:31 ET (00:31 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SHL.AU","symbol_name":"SONIC HEALTHCARE LTD","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2606220817","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2606220817","pubTimestamp":1769473860,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"0031 GMT - Sonic Healthcare gets a sell call from Citi, which says Australian Medicare data for pathology looks worse than it expected. \"Sonic's results are not perfectly correlated but we have halved our near-term growth forecasts for Australia revenue [circa 20% of the top line] to 2.5%,\" says analyst Laura Sutcliffe. Citi also thinks Sonic's U.S. business could continue to underperform. It points to mid-single digit growth estimates from larger competitors which have recently outperformed Sonic. \"Our 1H revenue estimates are near consensus, but we are 5% below for net profit,\" Citi says. \"We put in place a negative 30-day catalyst watch.\" It downgrades Sonic to sell, from neutral, and lowers its price target by 11% to A$21.00. Sonic is down 2.9% at A$22.66. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"SHL.AU":"SONIC HEALTHCARE LTD","BK4581":"高盛持仓","BK7124":"保健护理服务","XBI":"SPDR S&P Biotech ETF","LABU":"三倍做多标普生物-Direxion","XLV":"健康照护类股ETF-SPDR","BK4588":"碎股","BK4585":"ETF&股票定投概念"},"translate_title":"Sonic Healthcare因医疗保险数据担忧而受到新的关注——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SHL.AU":0.9,"XBI":0.6,"XLV":1.5,"LABU":0.6},"content_text":"0031 GMT - Sonic Healthcare gets a sell call from Citi, which says Australian Medicare data for pathology looks worse than it expected. \"Sonic's results are not perfectly correlated but we have halved our near-term growth forecasts for Australia revenue [circa 20% of the top line] to 2.5%,\" says analyst Laura Sutcliffe. Citi also thinks Sonic's U.S. business could continue to underperform. It points to mid-single digit growth estimates from larger competitors which have recently outperformed Sonic. \"Our 1H revenue estimates are near consensus, but we are 5% below for net profit,\" Citi says. \"We put in place a negative 30-day catalyst watch.\" It downgrades Sonic to sell, from neutral, and lowers its price target by 11% to A$21.00. Sonic is down 2.9% at A$22.66. (david.winning@wsj.com; @dwinningWSJ) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 26, 2026 19:31 ET (00:31 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"policyRegulatory","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}